QMA

Voyager Therapeutics, Inc. (VYGR) — QMA analysis

Sector: Healthcare · Market cap: $206M · Price: $1.74 · Data as of 2026-10-23

51
/100
C
Composite grade
Higher score than 75% of 22,734 tracked stocks

A composite score of 51/100 places Voyager Therapeutics, Inc. in the neutral band, higher score than 75% of 22,734 tracked stocks. The highest-scoring layer is Catalysts; the lowest is Relative strength.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 9 data layers say about VYGR

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)28/100
Earnings quality (EQS)70/100
Technical trend (TSS)46/100
Relative strength (RS)18/100
Momentum (USS)37/100
Insider activity (IAS)21/100
Off-exchange trading (FINRA) / large flows (WHS)24/100
Analysts / transcripts (ATS)91/100
Catalysts (XS)95/100

What does the QMA model currently show for Voyager Therapeutics, Inc.?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For VYGR the layers diverge — some score high (Catalysts), others low (Relative strength). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

VYGR insider & smart money activity

Over the recent period we record 0 reported insider purchases and 0 sales for VYGR: no reported insider trades in the period. A description of the data layer, not an instruction.

How VYGR compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for VYGR stock?

51/100 (grade C) as of 2026-10-23, fusing 9 data layers. An analytical score, not advice.

Are insiders buying VYGR stock?

Over the recent period, reported: purchases 0, sales 0. Insider activity: no reported insider trades in the period — a description of reported data, not a trade instruction.

Where can I see live VYGR data?

Live VYGR data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Explore more — for free

The VYGR score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full VYGR analysis with all layers and live data? Open VYGR detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]